Document is current
Any future updates will be listed below
-
Authors
Li, Shumin
Yan, Bin
Li, Thomas K. T.
Lu, Jianliang
Gu, Yifan
Tan, Yueqiu
Gong, Fei
Lam, Tak-Wah
Xie, Pingyuan
Wang, Yuexuan
Lin, Ge
Luo, Ruibang http://orcid.org/0000-0001-9711-6533
-
Funding
Funding for this research was provided by:
University Grants Committee (27204518)
University Research Committee, University of Hong Kong
Innovation and Technology Commission - Hong Kong (ITF/331/17FP)
Key Technologies Research and Development Program (2018YFC1004900)
Research Grants Council, University Grants Committee (17113721, 17117918)
- License Information
-
More Information
Article History
Received: 15 June 2022
Accepted: 26 January 2023
First Online: 14 February 2023
Declarations
:
: Blastocyst samples used in this study have been reviewed and approved by the Institutional Review Board (IRB) of China International Trust Investment Corporation - Xianngya (IRB Reference No. LL-SC-2020-004). The experimental methods were in compliance with the Helsinki Declaration. All participating patients provided written informed consent. Following the regulations of the Human Genetic Resources Administration of China, all genetic materials involved in this study have been reviewed and approved by Ministry of Science and Technology of the People’s Republic of China (Approval No. [2022] GH1831).
: Not applicable
: The authors declare that they have no competing interests.
